Literature DB >> 30031698

Incremental Prognostic Value of Myocardial Blood Flow Quantified With Stress Dynamic Computed Tomography Perfusion Imaging.

Satoshi Nakamura1, Kakuya Kitagawa2, Yoshitaka Goto1, Taku Omori3, Tairo Kurita3, Akimasa Yamada1, Masafumi Takafuji1, Mio Uno1, Kaoru Dohi3, Hajime Sakuma1.   

Abstract

OBJECTIVES: This study aimed to evaluate whether myocardial blood flow (MBF) quantified with dynamic computed tomography perfusion imaging (CTP) has an incremental prognostic value over coronary CT angiography (CTA) for major adverse cardiac events (MACEs) in patients with suspected coronary artery disease (CAD).
BACKGROUND: The incremental prognostic value of CTP over CTA is unclear. The quantification of MBF with dynamic CTP may potentially enhance risk stratification.
METHODS: A total of 332 patients (67% men; age: 67 ± 10 years) with suspected CAD who underwent CTA and dynamic CTP was analyzed. A MACE was defined as cardiac death, nonfatal myocardial infarction (MI), unstable angina, or hospitalization for congestive heart failure. A summed stress score (SSS) was calculated by adding scores of all myocardial segments according to normalized MBF values. Abnormal perfusion was defined as SSS ≥4. Obstructive CAD was defined as ≥50% stenosis in ≥1 vessel on CTA.
RESULTS: During a median follow-up of 2.5 years, 19 patients had a MACE. Multivariate analysis showed that, when adjusted for obstructive CAD on CTA, abnormal perfusion was significantly associated with hazards for MACEs (hazard ratio [HR]: 5.7; 95% confidence interval [CI]: 1.9 to 16.9; p = 0.002), with a significant improvement in the prognostic value. Abnormal perfusion was an independent predictor even when adjusted for ≥70% stenosis in ≥1 vessel (HR: 5.4; 95% CI: 1.7 to 16.7; p = 0.003) or adjusted for ≥50% stenosis in ≥2 vessels (HR: 6.5; 95% CI: 2.2 to 18.9; p = 0.001). In the setting of obstructive CAD, annualized event rates showed a significant difference between the patients with and without abnormal perfusion for all events (12.2% vs. 1.5%; p = 0.002) and for cardiac death and nonfatal MI (4.2% vs. 0%; p = 0.015).
CONCLUSIONS: MBF quantified with dynamic CTP has an incremental prognostic value over CTA. The addition of dynamic CTP to CTA allows improved risk stratification of patients with CTA-detected stenosis.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary CT angiography; coronary artery disease; dynamic CT perfusion

Mesh:

Year:  2018        PMID: 30031698     DOI: 10.1016/j.jcmg.2018.05.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  14 in total

Review 1.  Functional cardiac CT-Going beyond Anatomical Evaluation of Coronary Artery Disease with Cine CT, CT-FFR, CT Perfusion and Machine Learning.

Authors:  Joyce Peper; Dominika Suchá; Martin Swaans; Tim Leiner
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

2.  Clinical Validation of the Accuracy of Absolute Myocardial Blood Flow Quantification with Dual-Source CT Using 15O-Water PET.

Authors:  Masafumi Takafuji; Kakuya Kitagawa; Masaki Ishida; Yasutaka Ichikawa; Satoshi Nakamura; Shiro Nakamori; Tairo Kurita; Kaoru Dohi; Hajime Sakuma
Journal:  Radiol Cardiothorac Imaging       Date:  2021-10-28

3.  Prognostic value of CT-derived myocardial blood flow, CT fractional flow reserve and high-risk plaque features for predicting major adverse cardiac events.

Authors:  Lihua Yu; Zhigang Lu; Xu Dai; Chengxing Shen; Lei Zhang; Jiayin Zhang
Journal:  Cardiovasc Diagn Ther       Date:  2021-08

Review 4.  [Beyond Coronary CT Angiography: CT Fractional Flow Reserve and Perfusion].

Authors:  Moon Young Kim; Dong Hyun Yang; Ki Seok Choo; Whal Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-01-21

5.  Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II.

Authors:  Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-03-22       Impact factor: 9.130

6.  Myocardial perfusion assessment in the infarct core and penumbra zones in an in-vivo porcine model of the acute, sub-acute, and chronic infarction.

Authors:  Meng-Xi Yang; Hua-Yan Xu; Lu Zhang; Lin Chen; Rong Xu; Hang Fu; Hui Liu; Xue-Sheng Li; Chuan Fu; Ke-Ling Liu; Hong Li; Xiao-Yue Zhou; Ying-Kun Guo; Zhi-Gang Yang
Journal:  Eur Radiol       Date:  2020-11-06       Impact factor: 5.315

Review 7.  SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography.

Authors:  Jagat Narula; Y Chandrashekhar; Amir Ahmadi; Suhny Abbara; Daniel S Berman; Ron Blankstein; Jonathon Leipsic; David Newby; Edward D Nicol; Koen Nieman; Leslee Shaw; Todd C Villines; Michelle Williams; Harvey S Hecht
Journal:  J Cardiovasc Comput Tomogr       Date:  2020-11-20

8.  Myocardial Blood Flow Quantified by Low-Dose Dynamic CT Myocardial Perfusion Imaging Is Associated with Peak Troponin Level and Impaired Left Ventricle Function in Patients with ST-Elevated Myocardial Infarction.

Authors:  Jingwei Pan; Mingyuan Yuan; Mengmeng Yu; Yajie Gao; Chengxing Shen; Yining Wang; Bin Lu; Jiayin Zhang
Journal:  Korean J Radiol       Date:  2019-05       Impact factor: 3.500

Review 9.  Computed tomographic evaluation of myocardial ischemia.

Authors:  Yuki Tanabe; Akira Kurata; Takuya Matsuda; Kazuki Yoshida; Dhiraj Baruah; Teruhito Kido; Teruhito Mochizuki; Prabhakar Rajiah
Journal:  Jpn J Radiol       Date:  2020-02-05       Impact factor: 2.374

10.  Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia.

Authors:  Marc Dewey; Maria Siebes; Marc Kachelrieß; Klaus F Kofoed; Pál Maurovich-Horvat; Konstantin Nikolaou; Wenjia Bai; Andreas Kofler; Robert Manka; Sebastian Kozerke; Amedeo Chiribiri; Tobias Schaeffter; Florian Michallek; Frank Bengel; Stephan Nekolla; Paul Knaapen; Mark Lubberink; Roxy Senior; Meng-Xing Tang; Jan J Piek; Tim van de Hoef; Johannes Martens; Laura Schreiber
Journal:  Nat Rev Cardiol       Date:  2020-02-24       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.